New York City may join the upper ranks of some of the leading biotech cities like Boston Raleigh-Durham, and San Francisco with the opening of a new life sciences campus in 2021. Backed by investment group, Deerfield Management, the $635 million project, in partnership with the New York City Economic Development Corporation (NYCEDC), the approximately 300,000-square-foot life sciences space will be in housed within a 12-story building in Midtown Manhattan, and will include more than 200,000 square-feet of the space dedicated to wet labs...
Sorry, you need to subscribe to read this article.
If you would like to access this article, please subscribe below.
Premium subscribers receive complete access to our site content which includes market research and insights as well as coverage of the most important news, issues and events related to the healthcare technology industry.